ARCHIVES

NEJM Papers, Interview With NCI’s Doroshow, Provide Justification For Regulatory Action on ESAs.

This article is from The Cancer Letter archive.

Vol. 33 No. 23 | June 15, 2007

Download PDF Visit The Full Archive

Related Articles

FDA’s Oncologic Drugs Advisory Committee recommended approval of three drugs for cancer, voted down one.

September 16, 2005

Shubik Warns NCA Members They May Be Prober’s Next Target

May 22, 1981

ICCCR Loses Support Of French, DeVita Resigns As President, Fischinger To Take Over

July 17, 1992

Chemical Distribution To Grantees Delayed while HEW Considers Charging For It

June 22, 1979

H. Lee Moffitt Cancer Designated A Comprehensive Cancer Center By NCI.

May 4, 2001

NCI CTEP-Approved Trials For the Month of May

May 30, 2014